04.08.2020 • NewsAshlandAOCDede Willams

Ashland Sells Maleic Anhydride Portfolio to AOC

US chemical producer Ashland said it has reached a “definitive agreement” to sell its maleic anhydride (MA) business and the production plant at Neal, West Virginia, to AOC Materials for $100 million. The transaction is expected to close by the end of 2020, pending all approvals.

The business was not included in Ashland’s divestment of its composites business and its butanediol (BDO) plant at Marl, Germany, to the Ineos group in September 2019.

Dublin, Ohio-headquartered Ashland reacquired the 40-45,000 t/y West Virginia plant in 2010 from its former partner, Marathon Petroleum, based at Findlay. It had initially sold the facility to Marathon in 2005, along with its share in a former joint venture. It was Ashland’s only MA production asset.

Guillermo Novo, chairman and CEO of Ashland, said the divestment is part of the company’s drive to improve its margins by streamlining its portfolio and focusing on specialty ingredient.

AOC, based at Collierville, Tennessee, is a leading manufacturer of the chemical used as a feedstock for unsaturated polyester resins as well as in other large-scale coatings and polymer applications. Its CEO, Joe Salley, said the company plans to produce the additional MA volumes for its own internal consumption as well as selling some of it on the merchant market.

Ashland is selling its maleic anhydride (MA) portfolio and its plant at Neal,...
Ashland is selling its maleic anhydride (MA) portfolio and its plant at Neal, West Virginia, to AOC Materials for $100 million. The deal is due to close by year’s end. MA was excluded from Ashland’s sale of its composites business and BDO plant at Marl, Germany last year. (c) Ashland

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

most read

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.